arrow
M

Masashi Kudo

National Cancer Center Hospital East
H指数:13
被引数:574

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

T-cell receptor–engineered T-cell therapy using a glypican-3–specific TCR derived from a hepatoblastoma vaccine responder for HLA-A2–positive glypican-3–expressing cancers

使用源自肝母细胞瘤疫苗应答者的糖蛋白-3特异性TCR进行T细胞受体工程化T细胞疗法,以治疗HLA-A2阳性糖蛋白-3表达型癌症

2026-06-260
OAAI
Laparoscopic versus open liver resection in patients aged at least 80 years: retrospective propensity score-matched cohort study

腹腔镜与开腹肝切除术在年龄至少80岁患者中的比较:回顾性倾向性评分匹配队列研究

2025-12-010
OAAI
Response to Chemotherapy as a Key Factor in Time to Surgical Failure Following Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases: A Retrospective Cohort Study

化疗反应作为影响初始不可切除结直肠癌肝转移行转化肝切除术后手术失败时间的关键因素:一项回顾性队列研究

2025-11-280
PRE
Prognostic stratification of recurrent colorectal liver metastasis: impact of recurrence-free interval, tumor numbers, and size on repeat liver resection

复发性结直肠癌肝转移的预后分层:无复发生存期、肿瘤数量及大小对再次肝切除的影响

2025-11-210
PRE
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma

LEAP-002研究:lenvatinib联合pembrolizumab对比lenvatinib单药作为晚期肝细胞癌一线治疗的健康相关生活质量分析

2025-06-010
OA